Old Articles: <Older 211-219 |
|
National Defense November 2015 Yasmin Tadjdeh |
Training and Simulation Market Growing in India Opportunities are increasing for companies to sell simulation technology to the Indian army, said one foreign executive. |
Chemistry World March 6, 2015 Sanjay Kumar |
Scientists left unimpressed by Indian budget The Indian government's 'big-bang' budget has left the country's science community sorely disappointed. |
Chemistry World February 12, 2015 Rajesh Parishwad |
Indian chemical investment In 2007, India launched a major policy initiative to develop Petroleum, Chemicals and Petrochemical Investment Regions as a petrochemical hub in South Asia. |
Chemistry World February 12, 2015 Dinsa Sachan |
Target ignorance to tackle resistance After the discovery of the New Delhi metallo-beta-lactamase-1 (NDM-1) gene, which renders some bacteria resistant to most antibiotics, India has attracted global criticism for not being able to contain antibiotic resistance. |
Chemistry World February 12, 2015 S Umapathy |
Indian science at the crossroads How should Indian scientific research evolve? |
Chemistry World February 3, 2015 Sanjay Kumar |
India's chemistry challenges While India is yet to catch up with the global cutting edge technologies, some of its interventions have made global headlines. |
Chemistry World October 17, 2014 Dinsa Sachan |
Indian manufacturers hit back over quality claims The Indian pharmaceutical industry has asked its government to sue authors of a study published by the US National Bureau of Economic Research in early September. |
Fast Company Jeff Chu |
Indian PM Narendra Modi Brings Vision Of "Toilets Before Temples" To A U.S. Audience Indian Prime Minister Narendra Modi stood on a stage in Central Park and saluted 60,000 mostly youthful activists who had earned tickets to the Global Citizen Festival through their work against global poverty. |
Chemistry World September 25, 2014 Phillip Broadwith |
India backs off drug pricing controls The Indian government has intervened in an argument over pharmaceutical pricing controls. |
<Older 211-219 Return to current articles. |